Last reviewed · How we verify
Renal stent
Renal stent is a Small molecule drug developed by Bursa Postgraduate Hospital. It is currently FDA-approved for Ureteral obstruction relief, Post-urological surgery stenting, Malignant ureteral stricture management. Also known as: Renal stent for coronary artery.
A renal stent is a tubular medical device placed in the ureter to maintain patency and restore urine flow from the kidney to the bladder.
A renal stent is a small, cylindrical device used to open up narrowed or blocked renal arteries, typically made of a small molecule material such as chromic edetate. Renal stents are used to treat conditions such as renal artery stenosis, secondary hypertension, and kidney stones, among others, often in conjunction with medical therapy or other interventions like fractional flow reserve.
At a glance
| Generic name | Renal stent |
|---|---|
| Also known as | Renal stent for coronary artery |
| Sponsor | Bursa Postgraduate Hospital |
| Modality | Small molecule |
| Therapeutic area | Urology |
| Phase | FDA-approved |
Mechanism of action
Renal stents are typically used to relieve urinary obstruction caused by strictures, tumors, stones, or other pathology. The stent holds the ureter open, allowing urine to bypass the obstruction and drain normally. This prevents hydronephrosis, preserves renal function, and alleviates associated pain and infection risk.
Approved indications
- Ureteral obstruction relief
- Post-urological surgery stenting
- Malignant ureteral stricture management
- Benign ureteral stricture management
- Hydronephrosis prevention and treatment
Common side effects
- Stent migration
- Encrustation
- Infection/pyelonephritis
- Hematuria
- Flank pain
- Urinary frequency
Key clinical trials
- Ultra-low Dose Contrast for Endovascular Procedures
- A Comparative Study Between the Usage of Flexible and Navigable Suction Ureteral Access Sheath Versus Traditional Access Sheath in Retrograde Intrarenal Surgeries (NA)
- Double-J PLUS Postmarket Registry Study
- Investigating the Association Between Diagnostic and Therapeutic Management Models and Prognosis of Intrauterine Adhesions Based on a Large-Scale Prospective Cohort Study (NA)
- Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy (NA)
- A Prospective Randomized Trial Comparing the Effects of Anti-reflux Versus Standard Ureteral Stents on Male Sexual Function (NA)
- Safety and Efficacy of Traditional Versus Flexible and Navigable Suction Sheath in Retrograde Intra-Renal Stone Surgery (NA)
- Physician-Modified Endografts for Complex Aortic Aneurysms and Thoracoabdominal Aneurysm Repair in High-Risk Patients (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Renal stent CI brief — competitive landscape report
- Renal stent updates RSS · CI watch RSS
- Bursa Postgraduate Hospital portfolio CI
Frequently asked questions about Renal stent
What is Renal stent?
How does Renal stent work?
What is Renal stent used for?
Who makes Renal stent?
Is Renal stent also known as anything else?
What development phase is Renal stent in?
What are the side effects of Renal stent?
Related
- Manufacturer: Bursa Postgraduate Hospital — full pipeline
- Therapeutic area: All drugs in Urology
- Indication: Drugs for Ureteral obstruction relief
- Indication: Drugs for Post-urological surgery stenting
- Indication: Drugs for Malignant ureteral stricture management
- Also known as: Renal stent for coronary artery
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing